Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02510885 · ClinicalTrials.gov registry record · NA
SD-OCT Angiography
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT02510885 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 39 participants.
The verdict
NCT02510885, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The objective of this study is to image retinal vascular alterations in patients with retinal disease using the AngioVue OCT-A system and understand the information these images provide. The investigators will image study participants who have retinal diseases with the AngioVue unit (Optovue) and will collect relevant clinical data to understand the nature of the information contained in images obtained on AngioVue. This study being conducted under an abbreviated IDE. The investigators will analyze data using descriptive statistics. Risks related to light exposure will be managed by ensuring that the exposure to the AngioVue light source is well below maximum permissible limits for safe exposure.
Interventions
- DEVICE AngioVue SD-OCT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2015-07 |
| Est. Completion | 2019-03-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02510885
The ClinicalTrials.gov registry entry for NCT02510885 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AngioVue SD-OCT is the first listed.
NCT02510885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02510885 about?
NCT02510885 is a clinical study titled "SD-OCT Angiography". The objective of this study is to image retinal vascular alterations in patients with retinal disease using the AngioVue OCT-A system and understand the information these images provide. The investigators will image study participants who have retinal diseases with the AngioVue unit (Optovue) and wi...
What is the current status of trial NCT02510885?
This trial is currently terminated. It is a NA study. The enrollment target is 39 participants. The study started on 2015-07. Estimated completion is 2019-03-11.
What interventions are being tested in trial NCT02510885?
The interventions under investigation include: AngioVue SD-OCT (DEVICE).
Who is sponsoring clinical trial NCT02510885?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.